期刊文献+

泛素特异性蛋白酶18在恶性肿瘤发生和发展中作用及其机制的研究进展 被引量:1

Research progress on role and mechanism of ubiquitin specific protease 18 in the development and progression of malignant tumors
下载PDF
导出
摘要 恶性肿瘤给社会和个人带来了沉重的负担,提高肿瘤的早期诊断率和治疗效果、寻找潜在的治疗靶点成为目前临床上亟待解决的问题。泛素特异性蛋白酶18(USP18)是蛋白翻译后修饰酶的一种,具有去泛素化酶活性,能够特异性地将干扰素刺激基因15(ISG15)从底物蛋白上移除,也可调控干扰素信号通路,阻碍ISG的表达,在感染、免疫等病理过程中发挥作用。近年的研究发现,USP18在多种类型肿瘤中高表达,在肿瘤的发生和发展中扮演了重要角色,能够影响肿瘤增殖和凋亡,调控肿瘤细胞代谢、侵袭和转移。此外,USP18还可影响肿瘤细胞的放射和化学治疗的敏感性,并调控部分免疫细胞的功能。因此,开发USP18的特异性抑制剂,可能成为抗肿瘤药物开发的一种新思路。
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2022年第3期245-250,共6页 Chinese Journal of Cancer Biotherapy
基金 重庆市自然科学基金资助项目(No.cstc2019jcyj-msxmX0049) 重庆市科研机构绩效激励引导专项基金(No.jxyn2020-4) 重庆市技术创新与应用发展专项重点项目(No.cstc2019jscx-dxwtBX0023)
  • 相关文献

参考文献8

二级参考文献367

  • 1Yang Liu,Xiaojia Liu,Na Zhang,Mingxiao Yin,Jingwen Dong,Qingxuan Zeng,Genxiang Mao,Danqing Song,Lu Liu,Hongbin Deng.Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5[J].Acta Pharmaceutica Sinica B,2020,10(12):2299-2312. 被引量:30
  • 2Huan Deng,Songwei Tan,Xueqin Gao,Chenming Zou,Chenfeng Xu,Kun Tu,Qingle Song,Fengjuan Fan,Wei Huang,Zhiping Zhang.Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity[J].Acta Pharmaceutica Sinica B,2020,10(2):358-373. 被引量:8
  • 3Siddavaram Nagini.Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention[J].World Journal of Gastrointestinal Oncology,2012,4(7):156-169. 被引量:90
  • 4Liu LQ, Ilaria R Jr,Kingsley PD, et al. A novel ubiquitin- specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hema- topoietic cell differentiation[J]. Mol Cell Biol, 1999, 19 (4) :3029-3038.
  • 5Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes [J ]. Biochim Biophys Acta, 2004,1695(1/3) : 189-207.
  • 6Burkart C, Fan JB, Zhang DE. Two independent mecha- nisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus[J]. J Biol Chem,2012,287(7) :4883-4893.
  • 7Tokarz S,Berset C, La Rue J, et al. The ISG15 isopeptid- ase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase[J]. J Biol Chem, 2004,279 (45) : 46424- 46430.
  • 8Kim KI, Malakhova OA, Hoebe K, et al. Enhanced anti- bacterial potential in UBP43-deficient mice against Salmo- nella typhimurium infection by up-regulating type I IFN signaling[J]. J Immunol, 2005,175 (2) : 847-854.
  • 9Burkart C, Fan JB, Zhang DE. Two independent mecha- nisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus[J]. J Biol Chem,2012,287(7):4883-4893.
  • 10Chen L, Li S, McGilvray I. The ISG15/USP18 ubiquitin- like pathway (ISGylation system) in hepatitis C virus in- fection and resistance to interferon therapy[J]. Int J Bio- ehem Cell Biol,2011,43(10) :1427-1431.

共引文献980

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部